Balyasny Asset Management LLC Dexcom Inc Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Balyasny Asset Management LLC holds 22,000 shares of DXCM stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,000

Holding current value

$1.76 Million

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $28.2 Million - $51.2 Million	440,777 New	440,777 $29.5 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $31.7 Million - $38.9 Million	277,484 Added 8997.54%	280,568 $38.9 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $232,811 - $382,909	3,084 New	3,084 $382,000
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $6.82 Million - $8.06 Million	-65,608 Reduced 6.59%	930,319 $108 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $33.3 Million - $48.1 Million	391,766 Added 64.84%	995,927 $113 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $42.1 Million - $52 Million	-551,979 Reduced 47.74%	604,161 $48.7 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $69.7 Million - $136 Million	1,024,667 Added 779.37%	1,156,140 $86.2 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $8.79 Million - $12.2 Million	93,421 Added 245.51%	131,473 $67.3 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $4.94 Million - $6.2 Million	38,052 New	38,052 $20.4 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $6.87 Million - $11.5 Million	-109,586 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $298,352 - $472,158	-6,243 Reduced 5.39%	109,586 $29.5 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $1.45 Million - $2.26 Million	39,479 Added 51.71%	115,829 $25.3 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $1 Million - $1.24 Million	-28,252 Reduced 27.01%	76,350 $11.4 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $3.8 Million - $5.31 Million	-136,473 Reduced 56.61%	104,602 $15.7 Million
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $5.43 Million - $7.39 Million	193,479 Added 406.5%	241,075 $28.7 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $6.7 Million - $9.28 Million	-248,357 Reduced 83.92%	47,596 $5.7 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $190,979 - $300,332	8,179 Added 2.84%	295,953 $42.3 Million
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $1.48 Million - $2.12 Million	-84,111 Reduced 22.62%	287,774 $27.3 Million
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $118,349 - $168,009	9,062 Added 2.5%	371,885 $27.6 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $988,623 - $1.37 Million	88,905 Added 32.46%	362,823 $20.8 Million
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $3.11 Million - $5.2 Million	273,918	273,918 $13.4 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Dexcom Inc Transaction History